Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-methoxyphenyl 1-methyl-5-(4-methylbenzoylpyrrol)-2-acetamidoacetate
2. Amtolmetin Guacyl
3. Amtolmetineguacil
4. Artromed
5. Med 15
6. Med-15
7. Med15
8. St 679
9. St-679
1. 87344-06-7
2. 2-methoxyphenyl 2-(2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetamido)acetate
3. Artromed
4. Amtolmetin Guacyl
5. St 679
6. St-679
7. Med 15
8. Amtolmetin Guacil [inn]
9. Med-15
10. Finrid
11. Med15
12. 104076-16-6
13. 2-methoxyphenyl 1-methyl-5-p-methylbenzoylpyrrole-2-acetoamidoacetate
14. 323a00cro9
15. (2-methoxyphenyl) 2-[[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetyl]amino]acetate
16. Amtolmetin Guacil (inn)
17. N-((1-methyl-5-p-toluoylpyrrol-2-yl)acetyl)glycine O-methoxyphenyl Ester
18. 2-methoxyphenyl (2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetyl)glycinate
19. Eufans
20. Amtolmetine Guacil
21. Amtolmetina Guacilo
22. Amtolmetinum Guacilum
23. Amtolmetine Guacil [inn-french]
24. Amtolmetina Guacilo [inn-spanish]
25. Amtolmetinum Guacilum [inn-latin]
26. Unii-323a00cro9
27. Amtolmetin-guacil
28. Artromed (tn)
29. N-((1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetyl)glycine 2-methoxyphenyl Ester
30. Schembl24555
31. Mls006010220
32. Amtolmetin Guacil [mi]
33. Chembl1766570
34. Dtxsid50236291
35. Amtolmetin Guacil [mart.]
36. Chebi:135678
37. St679
38. Zinc596929
39. Amtolmetin Guacil [who-dd]
40. Bcp28767
41. Mfcd00866153
42. Stl451031
43. Akos015895070
44. Glycine, N-((1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetyl)-, 2-methoxyphenyl Ester
45. Glycine, N-((5-benzoyl-1-methyl-1h-pyrrol-2-yl)acetyl)-, 2-methoxyphenyl Ester
46. N-[2-[1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl]acetyl]glycine 2-methoxyphenyl Ester
47. As-30751
48. Smr004701308
49. Hy-107320
50. Cs-0028135
51. Ft-0659812
52. D07453
53. 344a067
54. A842102
55. Sr-01000945065
56. Q4748890
57. Sr-01000945065-1
58. (2-methoxyphenyl)2-[[2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetyl]amino] Acetate
59. 2-methoxyphenyl 2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrole-2-acetylamino)acetate
60. 2-methoxyphenyl 2-{2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetamido}acetate
61. 2-methoxyphenyl N-({1-methyl-5-[(4-methylphenyl)carbonyl]-1h-pyrrol-2-yl}acetyl)glycinate
62. 2-methoxyphenyl2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrole-2-acetylamino)acetate
63. (2-methoxyphenyl) 2-[2-[1-methyl-5-(4-methylphenyl)carbonyl-pyrrol-2-yl]ethanoylamino]ethanoate
64. 2-[[2-[1-methyl-5-[(4-methylphenyl)-oxomethyl]-2-pyrrolyl]-1-oxoethyl]amino]acetic Acid (2-methoxyphenyl) Ester
65. Amtolmetin Guacil; 2-methoxyphenyl 2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrole-2-acetylamino)acetate
| Molecular Weight | 420.5 g/mol |
|---|---|
| Molecular Formula | C24H24N2O5 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 420.16852187 g/mol |
| Monoisotopic Mass | 420.16852187 g/mol |
| Topological Polar Surface Area | 86.6 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 632 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Global Sales Information
ABOUT THIS PAGE
A Amtolmetin Guacil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amtolmetin Guacil, including repackagers and relabelers. The FDA regulates Amtolmetin Guacil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amtolmetin Guacil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amtolmetin Guacil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amtolmetin Guacil supplier is an individual or a company that provides Amtolmetin Guacil active pharmaceutical ingredient (API) or Amtolmetin Guacil finished formulations upon request. The Amtolmetin Guacil suppliers may include Amtolmetin Guacil API manufacturers, exporters, distributors and traders.
click here to find a list of Amtolmetin Guacil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amtolmetin Guacil written confirmation (Amtolmetin Guacil WC) is an official document issued by a regulatory agency to a Amtolmetin Guacil manufacturer, verifying that the manufacturing facility of a Amtolmetin Guacil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amtolmetin Guacil APIs or Amtolmetin Guacil finished pharmaceutical products to another nation, regulatory agencies frequently require a Amtolmetin Guacil WC (written confirmation) as part of the regulatory process.
click here to find a list of Amtolmetin Guacil suppliers with Written Confirmation (WC) on PharmaCompass.
Amtolmetin Guacil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amtolmetin Guacil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amtolmetin Guacil GMP manufacturer or Amtolmetin Guacil GMP API supplier for your needs.
A Amtolmetin Guacil CoA (Certificate of Analysis) is a formal document that attests to Amtolmetin Guacil's compliance with Amtolmetin Guacil specifications and serves as a tool for batch-level quality control.
Amtolmetin Guacil CoA mostly includes findings from lab analyses of a specific batch. For each Amtolmetin Guacil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amtolmetin Guacil may be tested according to a variety of international standards, such as European Pharmacopoeia (Amtolmetin Guacil EP), Amtolmetin Guacil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amtolmetin Guacil USP).
LOOKING FOR A SUPPLIER?
